These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22306065)

  • 1. Production and characterization of Clostridium perfringens recombinant β toxoid.
    Milach A; de los Santos JR; Turnes CG; Moreira AN; de Assis RA; Salvarani FM; Lobato FC; Conceição FR
    Anaerobe; 2012 Jun; 18(3):363-5. PubMed ID: 22306065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
    Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with recombinant Clostridium perfringens toxoids α and β promotes elevated antepartum and passive humoral immunity in swine.
    Salvarani FM; Conceição FR; Cunha CE; Moreira GM; Pires PS; Silva RO; Alves GG; Lobato FC
    Vaccine; 2013 Aug; 31(38):4152-5. PubMed ID: 23845812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
    Schoepe H; Pache C; Neubauer A; Potschka H; Schlapp T; Wieler LH; Baljer G
    Infect Immun; 2001 Nov; 69(11):7194-6. PubMed ID: 11598102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
    Jiang Z; De Y; Chang J; Wang F; Yu L
    Microbiol Immunol; 2014 Nov; 58(11):621-7. PubMed ID: 25197030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for
    Ding G; Bai J; Feng B; Wang L; Qiao X; Zhou H; Jiang Y; Cui W; Tang L; Li Y; Xu Y
    Virulence; 2019 Dec; 10(1):754-767. PubMed ID: 31429624
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers.
    Saleh N; Fathalla SI; Nabil R; Mosaad AA
    Anaerobe; 2011 Dec; 17(6):426-30. PubMed ID: 21664285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
    Schoepe H; Neubauer A; Schlapp T; Wieler LH; Baljer G
    Anaerobe; 2006 Feb; 12(1):44-8. PubMed ID: 16701610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous production and secretion of Clostridium perfringens beta-toxoid in closely related Gram-positive hosts.
    Nijland R; Lindner C; van Hartskamp M; Hamoen LW; Kuipers OP
    J Biotechnol; 2007 Jan; 127(3):361-72. PubMed ID: 16959352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
    Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
    Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.
    Lobato FC; Lima CG; Assis RA; Pires PS; Silva RO; Salvarani FM; Carmo AO; Contigli C; Kalapothakis E
    Vaccine; 2010 Aug; 28(38):6125-7. PubMed ID: 20670910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.
    Moreira GM; Salvarani FM; da Cunha CE; Mendonça M; Moreira ÂN; Gonçalves LA; Pires PS; Lobato FC; Conceição FR
    Sci Rep; 2016 Mar; 6():22816. PubMed ID: 27004612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cattle and goats' humoral response to vaccination with Clostridium perfringens type D purified epsilon toxoids.
    Oliveira RC; de Oliveira Júnior CA; Alves GG; Assis RA; Silva ROS; de Sousa Xavier MA; Lobato FCF
    Anaerobe; 2021 Dec; 72():102465. PubMed ID: 34662696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitoxin titer in colostrum and milk after vaccination of sows with Clostridium perfringens type C toxoid vaccine.
    Djurickovic SM; Dworak JE; Wickham KL
    Vet Med Small Anim Clin; 1975 Mar; 70(3):283-5. PubMed ID: 164076
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization of mice against alpha, beta, and epsilon toxins of Clostridium perfringens using recombinant rCpa-b-x expressed by Bacillus subtilis.
    Wang Y; Miao Y; Hu LP; Kai W; Zhu R
    Mol Immunol; 2020 Jul; 123():88-96. PubMed ID: 32447084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.
    Li Q; Xin W; Gao S; Kang L; Wang J
    Hum Vaccin Immunother; 2013 Nov; 9(11):2386-92. PubMed ID: 23835363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orally administered recombinant Lactobacillus casei vector vaccine expressing β-toxoid of Clostridium perfringens that induced protective immunity responses.
    Alimolaei M; Golchin M; Ezatkhah M
    Res Vet Sci; 2017 Dec; 115():332-339. PubMed ID: 28672254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme linked immunosorbent assay for potency testing of vaccines containing Clostridium perfringens type D epsilon-toxoid.
    Pfahler W; Bisesti E; Pereyra JB; Iribarren F
    Zentralbl Veterinarmed B; 1998 Apr; 45(3):133-9. PubMed ID: 9588107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.